March 11, 2014 |
The U.S. Food and Drug Administration has approved the marketing of an electronic medical device intended to treat migraine headaches. In an announcement released Tuesday, officials said the transcutaneous electrical nerve stimulation, or TENS, device was the first ever to receive such approval. The device, which will be marketed under the name Cefaly , is manufactured by Cefaly Technology of Belgium. "Cefaly provides an alternative to medication for migraine prevention," read a prepared statement from Christy Foreman, director of the Office of Device Evaluation at the FDA's Center for Devices and Radiological Health.
October 27, 2010 |
It’s no secret that the public health regulatory apparatus is stretched thin in many places, perhaps no component more so than the woefully understaffed food inspection side of the Food and Drug Administration. But say this for the FDA food police: When they do get around to looking a place over, they pay loving attention to detail. Acting on a court order sought by the FDA, U.S. marshals today seized an estimated $700,000 worth of adulterated rice and other food packaged in (unfortunately)
June 28, 2013 |
Is it hot in here, or am I just depressed? For many menopausal women, hot flashes are just depressing. And depression, which affects at least one in four women ages 40 to 59, can intensify the misery of hot flashes, as well. No surprise, then, that a pharmaceutical company came up with the idea to market an antidepressant for treatment of vasomotor symptoms, a.k.a. hot flashes. And on Friday, bucking the recommendation of its advisory committee on reproductive health drugs, the Food & Drug Administration approved the idea.
October 31, 2013 |
The U.S. Food and Drug Administration announced Thursday that it was stepping up efforts to prevent and address prescription drug shortages, calling the shortfalls a significant public health threat. In addition to expanding early reporting requirements for drug manufacturers, the FDA said it was launching a smartphone app that would give consumers instant information on pharmaceutical shortages. "The complex issues of drug shortages continues to be a high priority for the FDA, and early notification is a critical tool that helps mitigate or prevent looming shortages," said Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research.
May 4, 2013 |
WASHINGTON - The presence of caffeine in gum, jelly beans, waffles and other foods has prompted the Food and Drug Administration to investigate the stimulant's potential effects on children and adolescents. The FDA's announcement comes a few weeks after gum maker Wrigley introduced its Alert Energy Caffeine Gum. Each piece of the gum contains about as much caffeine as a half-cup of coffee, according to a consumer update that the FDA posted on its website Friday. The update provided more information on an investigation the FDA announced earlier this week.
July 3, 2013 |
Arsenic is one dangerous pollutant that can occur naturally (though it also can be a byproduct of pesticide use or certain kinds of mining), usually ingested via water. In Nepal and other impoverished areas of Asia where arsenic levels are high, low-tech water filters make a huge difference - a jar filled with rusty nails and sand. The ferrous oxide in the nails binds to the arsenic; particles then are filtered out in the sand. That works for households but not for rice fields, where immense amounts of water are used.